Immune checkpoint inhibitor-induced colitis as a predictor of survival in metastatic melanoma.
Hamzah Abu-SbeihFaisal S AliWei QiaoYang LuSapna PatelAdi DiabYinghong WangPublished in: Cancer immunology, immunotherapy : CII (2019)
GI-irAEs are associated with improved OS and PFS in patients with metastatic melanoma. Furthermore, higher grades of diarrhea are associated with even better patients' OS rates.